Q2 2024 Cibus Inc Earnings Call
you
Speaker Change: Please stand by. Your program is about to begin. If you need audio assistance during your call today, please press star zero.
Speaker Change: Good day and welcome to the CIBUS second quarter 2024 results conference call. All participants will be in a listen-only mode.
Speaker Change: After today's presentation, there will be an opportunity to ask a question. Please also note today's event is being recorded. At this time, I'd like to turn the conference over to Wade King, Chief Financial Officer. Sir, please go ahead.
Speaker Change: Thank you and good afternoon. This is Wade King, the Chief Financial Officer at Cibus. I would like to thank you for taking time to join us for Cibus' second quarter of 2024 financial results and corporate update conference call and webcast.
Speaker Change: Presenting with me today is Rory Riggs, our co-founder, chief executive officer and chairman, and Peter Beetham, co-founder, president, and chief operating officer.
Speaker Change: Before we begin the call, I'd like to remind everyone that statements made on the call and webcast, including those regarding future financial results and future operational goals and industry prospects, are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the call.
Speaker Change: Please refer to SEVA's SEC filings for a list of associated risks.
Speaker Change: This conference call is being webcast. The webcast link along with our press release and corporate presentation are available on the investor relations section of CBIS.com to assist in your analysis of the business.
Speaker Change: With that, I would now like to turn the call over to Mr. Riggs.
Rory Riggs: This conference call is being webcast. The webcast link along with our press release and corporate presentation are available on the Investor Relations section of Peter.com to assist in your analysis of decisions. With that, I would now like to turn the call over to Mr. Riggs. Go ahead, Rory. Thanks, Wade. I would like to begin this call with a high-level update on why we are so excited with our progress. Following my remarks, Peter will walk you through our recent developments in more detail. When we emerge, he will review the value proposition for all of our developers. When we emerge, we will discuss how we are doing on our projects in terms of owning a foundational view.
Speaker Change: Thank y'all again for being and having a good session with our progress.
Peter Beetham: These coverage includes the proprietary use of the financials, the foundational intellectual property in the agricultural machine editing industry, including our broad editing technology platform.
Peter Beetham: When we merged, we were the two leading gene-editing companies in terms of the exclusive use of CRISPR technology for gene-editing in agriculture. When we created this gene-editing platform, we had established the use of the foundation of the gene-editing training that our approach would be made across, including our bronze-editing technology platform, we formed the exclusive use of TALENs in agriculture, and raised certain geographies to execute the use of CRISPR technology. These companies on an annual basis paid billions of dollars to grow this gene-editing trade development. We in a state of mission to become the leading independent gene-editing trade developer for the major crops, canola, rice, and other plant-related attributes such as herbicide tolerance and disease resistance.
Peter Beetham: The example of our trade news strategy is the trade we have developed on oversight tolerance. Oversight tolerance trades are the mainstay of the GMO trade industry.
Speaker Change: The principal attribute of a herbicide-tolerant plant is that a trait enables plants to survive when a farmer is afraid of herbicide-resistant plants. In other words, a great example of a farmer's stick strategy is when herbicides develop without herbicide tolerance.
Speaker Change: The GMO herbicide-tolerant traits were developed using foreign materials from other plants. And as such, the principal attribute of herbicide-tolerant traits is that the trait enables GMO trait innovation in crops, such as rice and wheat herbicides on the plant. The difference, in other words, is that these traits enable farmers to kill the wheat with herbicide-tolerant traits without using any foreign material. The GMO herbicide-tolerant traits were developed using foreign materials from other plants. And as such, they face severe regulations or bans. This is why, globally, GMO traits are changing to regulate the traits from our technology. The difference is that with our genetic technology, we can develop herbicide-tolerant traits without using any foreign materials. Our herbicides are indistinguishable from traits developed by other plants.
Speaker Change: that you did not have three of those traits.
Speaker Change: In addition, while I think that's great opportunity and regulations are changing and giving regulations that don't use a lot of technology. It's because it's a completely required to develop. This is why we're excited about the prospects for a race and we've created these resistant trade-in that are the perfect animal, the proper size resistant trade-in. These resistant trade-in, we're initially focused on not having your way to the old trade-in. They're quickly in the relationship. In the old, it's created opportunity in various ways. It's a very specific technology farming. You can easily complex the required and they fill it with trust. The promised machine editing is that they can address these. There is, like, crazy, or appropriate example of complex trade. This is why, in trade-in, it makes this land-graves. We're initially focused on determining where white oil is for these ethos. It's a critically important agricultural trade-in world. So it'd be very similar to them.
Speaker Change: and these people are ain't see every day, right? Positive impact of the farming and yielding for technologies and alleviating the drug. The promise of gene at our virtually, and they know that drug is pretty related to the disease of the room's district. Nor seed comes alive and mayors are going to plant and do not today, and the difference at the Royal Court of Children's Park is for licensed agricultural trade priorities are very similar to the massive world today, it is our pharmaceutical industry. Using our knowledge, sorry to take with knowledge you love, we can develop, compare like we need to. We're going to produce this reaction to the time of the cost of the original. We can, I would be able to make your current. And now, we're going to be able to accelerate parties, have rewards, technology, and their products.
Speaker Change: When we announced our merger, we established major milestones to track our progress in becoming the leading trade developer. We can develop a complex seed trade, a fraction of the time and cost of inventing our GMO breed. And, with our new technology, we were able to accelerate the path to follow our progress in developing new crop platforms and technologies.
Operator: Please stand by; your program is about to begin. If you need audio assistance during your call today, please press star zero. Good day, and welcome to the CIBUS second quarter 2024 results conference call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask a question. Please also note that today's event is being recorded. At this time, I'd like to turn the conference over to Wade King.
Speaker Change: We just have an employee who are mowing up their drivers for our dogs that are off and being an operating unit by the bill we have to see a couple of our expenses. So we've been planning for May 2020 for our poor and our recent patents. We've provided our new technology to three categories. Second first.
Wade King: Thank you and good afternoon. This is Wade King, the Chief Financial Officer of Cibus. I would like to thank you for taking the time to join us for Cibus' second quarter 2024 financial results and corporate update conference call and webcast. Presenting with me today is Rory Riggs, our co founder, chief executive officer, and chairman, and Peter Beetham, co founder, president, and chief operating officer. Before we begin the call, I'd like to remind everyone that statements made on the call and webcast, including those regarding future financial results and future operational goals and industry prospects, are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the call.
Wade King: Please refer to CIBUS's SEC filings for a list of associated risks. This conference call is being webcast. The webcast link, along with our press release and corporate presentation, is available in the investor relations section of cibus.com to assist in your analysis of the business.
Speaker Change: Nude Riggs.
Speaker Change: [inaudible]
Speaker Change: [inaudible]
Wade King: This conference call is being webcast. The webcast link, along with our press release and corporate presentation, is available in the Investor Relations section of Cibus.com to assist in your analysis of the business.
Wade King: With that, I would now like to turn the call over to Mr. Riggs. Go ahead, Riggs. Thanks, Wade. I would like to begin this call with a high-level update on why we are so excited about our progress.
Speaker Change: We are rapidly establishing ourselves as a leading trade innovator and developer, as addressing unique needs within these major crops. It will be critical in solving the world's challenges, interests, creeds, and accomplishments. And the next quarter was another strong quarter for our commercial and technological progress. Most importantly, the CAPs were built in the first decade and continued to meet our milestones. We are rapidly establishing ourselves as a leading trade innovator and developer, as addressing unique needs within these major crops. I want to highlight a couple of key accomplishments supporting our trade portfolio. Reflecting on our recent accomplishments, the second quarter was another strong quarter for our commercial and technological progress. We successfully completed an edit in our commercial and technological progress. We successfully completed an initial edit for our first load of action for our nutrient use efficiency trade.
Rory Riggs: and Ron Hebner, and no one in society can do it without their families.
Rory Riggs: When we merged, we were the two leading key netting companies in terms of owning a foundational pathway for people to understand why we are so excited with our progress. These cover exclusive proprietary use of the financials, the foundational intellectual properties in the agricultural green netting industry, including our broad green netting technology platform, the Exclusive User Retailer, and agricultural green netting companies in terms of the ownership of foundational technology for gene editing and agriculture.
Speaker Change: and Peter, we'll take a deeper dive, we'll start in the amount of a highlight as people are on the top of the news set for the 14th, our trade portfolio. Traditionally, we are making great for our order. We want to take a couple of places out of the train, our platform, our horizon mode, and that corridor is kind of everything in the event of us, one of the largest sites, so you can put it in that commercial edit, we bring to us, the mode in our race parties, we're in neutral, we're using competition to U.S. and Latin American both of these, in our area of America, and we love our unnarodics to a new sub-serudutrients in the U.S. Traditionally, we're making great, we're using remote-using algorithms, ideally, all the other ways to support platforming, as in its corridor, all the countries in the right of us, building our courage, our quality platform, and the right of us, it brings our race partnerships, and we will be meeting a couple of new people in U.S. and Latin American communities in the United States, and in our press on the America, in Maryland, and the nation.
Rory Riggs: When we created this gene editing powerhouse, we had a state of mission to become the leading foundational gene editing training company in the agricultural green netting industry, including our broad green netting technology platform, the Exclusive User Retailer, and agricultural green netting companies in terms of the foundational intellectual properties in the agricultural green netting industry. When we created this gene editing powerhouse, we had a state of mission to become the leading independent gene attribution or genetic expression of a major crop, canola, or other plant-related attributes such as herbicide and polymorphic disease resistance.
Peter Beetham: both in addition to the recent report of the importance of yielding and the fact that we are in progress commercially and our momentum in building our herbicide targets by new technologies is important. With that, I'll pass the call over to Peter. Peter, thank you, Rory, and good afternoon to everyone. It really has been a transformative first half of 2024 for Tebas. Marking significant progress in our commercial development, our herbicide progress commercially, and our momentum in developing new traits and new technologies.
Rory Riggs: The principal attribute of a herpetogenetic extraction plant is that it enables plants to survive.
Rory Riggs: Collard's herbicide-resistant plant. In other words, these traits enable our tree to grow.
Rory Riggs: Herbicide-tolerant crates were developed using GMO materials from other plants. And as such, the severe regulations for banning crates, which virtually stopped their production.
Rory Riggs: This is why we have virtually stopped GMO trade innovation in crops, such as rice and wheat herbicides on the plant. The difference, in other words, is that these traits enable farmers to kill weeds with herbicide-tolerant traits without using any foreign materials. The GMO herbicide-tolerant traits were developed using individual materials from other plants and conventional breeding, but they faced severe regulations or bans. This is why we have virtually stopped GMO trade innovation in crops such as rice and wheat.
Peter Beetham: I'd like to re-emphasize how far our service has come. Thank you Rory, and good afternoon to everyone. It really has been a transformating first half of an annually occurring royalty stream.
Peter Beetham: [inaudible]
Rory Riggs: and Paragulates, the Trashway Army Technology, is a different mission with our team.
Peter Beetham: importantly with the new we continue to move our customers right
Rory Riggs: This is why, globally, regulations are changing to make it difficult to detract from our technology as it raises the complexity required to do so.
Speaker Change: And we've been developing for a while and I would mention that I will try like explaining
Speaker Change: For each trade, field trials validating their effectiveness are a critical element.
Speaker Change: [inaudible]
Peter Beetham: On one side, you see a crop that has five herbicide applications, one after first reviewing, and on the other side, you see the control crop that didn't contain outcaters, and the crop was devastated by the herbicide.
Peter Beetham: Excitingly, earlier this week, we announced yet another milestone to rise, where we initiated the first
Peter Beetham: [inaudible]
Speaker Change: These trades can provide an excellent weed management solution that creates valuable seed burning rights, seed company customers and more profit and sustainable options for farmers.
Rory Riggs: When we announced our merger, we established major milestones to track our profits and become a leading trade developer. The complex seed trade is a fraction of the time and cost of conventional or GMO breeders, and with our technology, we were able to accelerate the path of our commerce.
Peter Beetham: Today, I'd like to focus on a couple of key areas of achievement, first being the further expansion of our developed rice platforms, these trades can provide an excellent weed management solution, and the second being breakthroughs in canola, value for the confirmed edits in canola for our more profitable and sustainable options for farmers. Today, I'd like to focus on a couple of key areas of achievement, first being the further expansion of our developed rice platforms, these trades can provide an excellent weed management solution, and the second being breakthroughs in canola, value for the confirmed edits in canola for our more profitable and sustainable options for farmers.
Rory Riggs: Crop Platform Technology. This, for example, has made major milestones in the recent development of an on-breeding platform for wheat, our expected soybean plantings in 2024, and our recent patent expansions for new technology. We divided our milestones into three categories.
Rory Riggs: Also known as Follow Our Progress in developing new productivity platforms and signing agreements with seed companies. This, for example, means providing updates on a related project.
Speaker Change: which coincided with our recording of the local field trials held in January 2024, underscoring the significant market potential we see in rice.
Rory Riggs: We've tried to follow our progress in development.
Speaker Change: In addition, this last quarter, we observed initial trials and are experiencing further weakening cuts with emotion demand for our HG1 and HG2 areas.
Rory Riggs: This means providing up-to-date regulatory developments within our trade portfolio.
Rory Riggs: Association of the Heroes, we have such a ranking and a good sort of merchandise box for Burleson.
Speaker Change: As we've discussed before, rights represent a major opportunity given the industry's continued challenges and significant market opportunities we see in rights.
Rory Riggs: Sir, we're disappointed in the delay in final regulatory approval. We track milestones following progress in gaining regulatory approval, and other countries globally, like Canada and the UK, are continuing to do so.
Speaker Change: [inaudible]
Rory Riggs: Here, we have been tracking the rate of separation of the United Kingdom under a global view, which is the reason for using approval convention rules in the UK and the positive parliamentary vote in February. We continue to see a groundswell of support for international and final regulatory approval of the EU. To be the technology posted will be critical to solving the world's challenges and address food scarcity in the next generation.
Rory Riggs: We continue to see ground as well as support internationally addressing the unique needs of these major crops that will be critical in solving the world's challenges.
Speaker Change: Our current partnership for Asia as well could provide access to 6 million mind states. In addition to our momentum in life, we continue to make progress in Canola. We are doing important field trials in Canola and we want to see growth in the U.S., Canada and the U.K. The United States and Latin American markets are our primary focus for life. In addition, we successfully made and have a developing strategic partnership for Asia as well, which I'll turn to now.
Rory Riggs: Reflecting on our recent accomplishments in the next sector quarter, it was another strong quarter for our commercial and technological growth.
Peter Beetham: Peter will take a deeper dive into our recent program, but I want to highlight a couple of key accomplishments supporting our trade portfolio. Reflecting on our recent accomplishments, the second quarter was another strong quarter for our commercial business, and the third quarter was another strong quarter for our commodity business.
Speaker Change: In addition to our momentum in the market, we continue to make progress in canola. We are doing important field trials in canola annually.
Speaker Change: The enormous commercial opportunities in these three trade areas are not only the clear value of productivity and sustainability, but these trades also represent significant opportunities which will in turn be expanded to other crops.
Peter Beetham: Both of these are extremely important as we broaden our opportunities set for new trades, and our trade portfolio.
Peter Beetham: Commercially, we are making great progress in launching our herbicide policy in our partner market. In this quarter, we signed an agreement with Veteras, one of the largest rice-seeding companies in Latin America, which brings us the mode of action for a nutrient-induced deficiency in the U.S. and Latin America. Both of these are currently in import, and we have brought in our next two new sub-series nutrients into the U.S. Commercially, we are making great progress.
Speaker Change: Advances in canola include disease resistance, this quarter we have successfully completed nutrient use efficiency in our canola franchise.
Speaker Change: [inaudible]
Peter Beetham: Commercially, we are making great progress in promoting our herbicide-tolerant trade support platform in writing. As in this quarter, we are trying to improve in writing.
Peter Beetham: Building our herbicide-tolerant trade platform in Latin America is important to us. It brings our rice partnerships to the forefront, leading companies in the U.S. and Latin America. We expect to continue to expand our cross-zones in North America, the Americas, and Asia.
Speaker Change: [inaudible]
Peter Beetham: back in 24 and 25 to continue to expand our presence in the Americas and Asia.
Speaker Change: [inaudible]
Peter Beetham: It really has been a transformative year.
Peter Beetham: These milestones continue to demonstrate our great progress commercially and in the global regulatory land trade and new technologies.
Speaker Change: We also have a season in the Ramon Islands where we've seen the initial editing, we'll see with some model of tricks.
Speaker Change: We believe this to be the first NUE gene in a major crop in North America. This is a significant milestone, not just for our company, but for the entire agricultural industry. We also achieve that there is mounting pressure on crop production to use fewer fertilizers produced using the NUE trait.
Peter Beetham: We believe we are making progress in our commercial development.
Peter Beetham: We continue to move in the global regulatory landscape.
Peter Beetham: I'd like to re-emphasize how far our learning has come.
Peter Beetham: While it can be challenging to appreciate the arduous path towards generating an annual reoccurring world history, we believe we are very close.
Peter Beetham: and the annual reoccurring 12-week training. We believe we are the new repository. Importantly, we continue to move our customer traits through the development phase and our multiple field trials. By explaining how we see commercial development, field treatments validating their effectiveness are a critical element and an important milestone towards ultimate commercialization.
Speaker Change: We believe this is important. First, NUE traits are part of a very large category of traits relevant to all crops. These traits have the potential to make fertiliser use more efficient on a global agricultural industry. Without compromising the views that farmers expect and rely on, in essence, NUE traits would provide a solution to optimise farmers' agricultural practices while maintaining productivity. This achievement is also significant because it represents our first use These traits have the potential to make fertiliser use more efficient on a global basis. Without compromising the views that farmers expect and rely on, in essence, NUE traits would provide a solution to optimise farmers' agricultural practices while maintaining productivity.
Peter Beetham: Ward, Oxford Commercialisation, and Custover Crop Genetics; they provide them with a new deal.
Peter Beetham: As our editors note, these small-scale field trials of the trait's effectiveness are invaluable to our commercialization project.
Peter Beetham: Oh, again, they have some big closeness, all right.
Peter Beetham: We've experienced this with each of our development teams, with customers signing on.
Peter Beetham: So, thank you.
Speaker Change: of the tribe.
Speaker Change: This achievement is also significant because it represents our first use of the trait machine ProSense traits to operationalise third-party developed traits.
Peter Beetham: It's a clear example of stem cells.
Speaker Change: This demonstrates our company's ability as a development partner to take gene-edited platforms identified by third parties and potentially make edits to the, but larger, developed global grain crop as measured in plant data. In addition to the achievements within our pipeline of developed and advanced traits, we continue to make progress with our crop platform.
Peter Beetham: On the one hand, we've experienced this with each of our development side applications.
Peter Beetham: Excitingly, earlier this week, we announced yet another milestone in our lives, where we initiated the first StatsGeneHack.
Peter Beetham: In this case, we reported that the trait effectiveness was also promising after an initial field trial. These traits can provide an excellent weed management solution. Excitingly, earlier this week, we announced yet another milestone in rice, where we initiated the More Profit and Sustainable Opportunity.
Peter Beetham: This is Peter Beetham, and we have been actively engaged in such a long and we can't just see a couple of people fighting us and defend ourselves as well as the virus, as we thought it was a global green, a key, and we'll measure them as those discussions.
Speaker Change: Based on these discussions, we believe we are on track to enter into major challenges with wheat farmers worldwide. Since achieving this breakthrough, Nishay and I have been actively engaged in discussions with potential seed company partners. Finally, our advanced soybean being a key for starting up discussions for us.
Peter Beetham: I'd like to focus on a couple of key areas of achievement.
Peter Beetham: These trades can provide an excellent lead management solution, and the second being breakthroughs in canola, value perceived confirmed edits in canola for our advanced trades.
Speaker Change: And as I mentioned before, we believe we are on track to enter into initial development and commercial progress related to this industry. We also expect to initiate the first edit of the course in 2020 by the end of 2024.
Peter Beetham: Today, I'd like to focus on a couple of key areas of achievement, the first being the further expansion of our developed rice platforms; we've gained significant commercial momentum in rice, and the second being increasing customer demand for our HT1 and HT2 traits, which coincided with our recording of the successful field trial back in January, 2022.
Speaker Change: Finally!
Speaker Change: And the chairman will align the penitentiary point at the time. I'm not very excited about it. You can come up with this over in a day. You can come up with one of the most challenging endeavors in France. But more than just about market size. I mean, maybe 30 pounds. So he beat me up. He'll end up with a set of pounds there. You're operational for hours. It's inevitable. The ingredients that is needed by the team. Just like when he can't complain about our company's long-term growth status treatment would allow. We can think that we are actually the... ...in being in terms of a lot of a standard million carbon green and the tools for the consumers. It's about much good industry. We expect our soybean fiber. How gold is it? The founder can create product for our sustainable and greening it. There's the impact we provide. Our key to the doubt is about our company's long-term growth status treatment.
Peter Beetham: In addition, this last quarter, we have observed initial trials showing an amazing opportunity to further weaken customer solutions demand.
Peter Beetham: As we've discussed before, Rice represents a major opportunity given the industry's continued challenges in developing the financial economy. In addition, this last quarter, we approved an initial trial of herbicide policy.
Speaker Change: And with that, we're going to talk a little bit about being able to write and being able to do that on a sustainable way, low carbon and gradient in the cereals for the consumers.
Peter Beetham: We need to further move on 90% of canola...
Peter Beetham: Canola, soybean, and the traits I mentioned earlier.
Speaker Change: Our goal with this business is to be able to create products that do not negatively impact the environment through production, use, or disposal. And with that, on behalf of the Corp of Wade, we can review our financials. Wade, that's you. Thank you.
Peter Beetham: for similar uptake in rice farming and the limitations of current agricultural technologies.
Peter Beetham: A major opportunity given the industry's continued challenges in dealing with our ranched and herbicide problems.
Peter Beetham: and over 90 cuts of by, and almost not being in court yet.
Peter Beetham: I like both, and then hang in there, and you're good.
Peter Beetham: I guess I'll meet them, we'll count, and I'll end the night.
Peter Beetham: We are working with our right to have a safe and secure market, which is our primary focus for life.
Peter Beetham: Prime Ministers that have a developing strategic partnership with Asia.
Peter Beetham: In addition to our minds, I think,
Peter Beetham: We continue to make progress in canola. We are doing important field trials in canola, and we're close to a million dollars in the U.S., Canada, and Latin American markets.
Speaker Change: [inaudible] and in his arms and in his arms and in his arms and [inaudible]
Peter Beetham: successfully made have a developing strategic partnership.
Peter Beetham: In addition to our most advanced trades in canola, we continue to make progress in canola. We are doing important field trials of canola and oilseed rape in the US, Canada, and the UK.
Peter Beetham: In addition, we successfully made significant progress on these traits in our Advanced Trait Pipeline. We hope to continue this work in the future.
Peter Beetham: Now it's time to get up a shade to be expanded to
Peter Beetham: ... ... ... ... ... ... ... ...
Speaker Change: [inaudible]
Peter Beetham: Not only is the clear value of productivity and credibility.
Peter Beetham: Thank you all for attending.
Peter Beetham: and an incredibly important step to provide Norah and anticipate three pounds of Norah food later this year.
Peter Beetham: We believe this trait, once available, has the potential to change lives at any time.
Peter Beetham: to be the first genetic report to achieve 100 million active appealers use.
Peter Beetham: Representing one of the hermit sites, one of our largest...
Speaker Change: Expoval, Enoch, Cheshunkham, with a number of thousands of the 20,000 to 20,000 to 20,000 to 20,000 to 20,000 to 10,000, and then board lay a 20 point in the cream chain of the church going here on the map.
Peter Beetham: And a further reminder that Claretinia and Nantoo are multi-stop trains, meaning that the efficacy we expect to achieve in this trial has not yet been achieved.
Peter Beetham: I have...
Peter Beetham: to be the first gene editor to ever receive $100 billion in royalties.
Speaker Change: Thanks Wade and Peter. As you explained, this quarter has been very important for a number of reasons. This has been an important period for building our weed management platform in Rice. At the end of the quarter, with four leading seed company customers in Rice, representing approximately 40% of the addressable acres. In addition, with our recent field studies for site and traders, we've begun to build our product off the ground. As you explained, this quarter has been very important for a number of reasons. This has been an important period for building our weed management platform in Rice.
Peter Beetham: We also achieved an important milestone with the initial editing.
Peter Beetham: We believe this to be the first NUE trace in canola.
Peter Beetham: I believe this to be the first N.U.E.G.
Peter Beetham: This is a significant milestone and notable crops for our company.
Peter Beetham: I'm sorry, Mark. We'll be back. I'm sorry, Mark.
Peter Beetham: I have a lot to say on that.
Peter Beetham: There is mounting pressure on crop production to receive a cure for fertilisers.
Peter Beetham: as producers using the NUE trade in canola.
Peter Beetham: are part of a very large category of trades relevant to the United States.
Speaker Change: [inaudible]
Peter Beetham: This is a significant milestone not just for our company but for the entire agricultural industry. Without compromising yield, farmers expect animals to use fewer fertilizers than they should, using a cross-fueled fuel.
Speaker Change: and inspection to be the back where the Rory Riggs and the Field Squad are the back and trade with these. We've begun to build a computer of our truckers to have a show ourselves. There's no need to call these questions. It's a solution in the important right thing.
Peter Beetham: Let me explain why this is so important.
Peter Beetham: This achievement is also significant because it represents our first generation of youth of the 21st century.
Peter Beetham: The trade machine may facilitate its use more efficiently on a global basis without compromising the yield that farmers expect.
Speaker Change: The progress in advanced trades is key, because they are the backbone of our current trade offering in canola, where we have 10 customers. In addition, these trades are expected to be the backbone of our product offerings in soybeans.
Peter Beetham: In essence, NUHG has netted a solution to optimize urban agriculture successfully.
Speaker Change: And this concludes our remarks, operator.
Speaker Change: You can go over the call for questions.
Peter Beetham: This achievement is also significant because it represents our first use of the Trait Machine process to operate a machine.
Speaker Change: Finally, we will take care of our humans from Agot Quarton, which we offer at our one line until it's on keep pass.
Nick Offerstadt: You may withdraw your questions. Hey, good afternoon. This is Nick Offerstadt. Congrats on the quarter. The first one for me, just on the soybean side, getting up to feed there. I wanted to unpack that market opportunity a little more and just the timing around monetizing and maybe reaching some of the other milestones you've mentioned, achieving in that segment. Just a little more color on the soybean side would be helpful. Thank you.
Peter Beetham: This demonstrates how early this year we substantially completed our Keynetter platform in a week, providing us with...
Peter Beetham: Providing us with the potential to make it to the largest group of people in the world.
Speaker Change: [inaudible] that's that's [inaudible]
Peter Beetham: Since achieving this this year, we have been actively engaged in discussions in which we
Peter Beetham: Thanks for letting us go, Phil. We believe we are on track.
Peter Beetham: We are on track to enter into major challenges for wheat farmers worldwide.
Peter Beetham: this year. Since achieving this breakthrough in wheat, we have been actively engaged in discussions with potential seed company partners, with herbicide companies, and disease and advanced source companies.
Peter Beetham: And, as I mentioned before, one of the most challenging and dumbest acts of all time.
Speaker Change: and Harry Potter was on, or are you wondering how to produce EDM, or are you going to produce a 5-year life in America, or are I am interested in our clients, the circles of the art of science, and editing, and accounting, we can learn together, and like you're in this year. And so, we've just sent us to work again next year, type line, and we're in the development of pipeline, is the balance of this way of being, that we would like my words.
Peter Beetham: Finally, our team would allow us to penetrate...
Peter Beetham: We are making steady progress, and we still aim to serve as the foundation of the economy.
Speaker Change: signed with each of the partners. There's a big movement by all the consumer products companies, goods companies, the largest companies in Latin America may have entered into a crop which I will start by editing or a crop, so we can increase our money to work with us to develop and alternate in developing a platform where soybean is going to be our key component. There's a big movement by all the consumer products and packaged goods companies
Peter Beetham: will be operational for our sustainable energy system, which is a key component of our company.
Peter Beetham: We see a significant opportunity in being able to develop 200 million carbon ingredients and materials for the consumer and goods industry.
Peter Beetham: Our goal is to serve as the foundation for sustainable development.
Peter Beetham: do not negatively impact the environment during production use or disposal.
Speaker Change: and number of the energy and personality that are properly piloted like whales, whichever is piloted in. The second release builds a new brand new industry increase in our state of degrees, as those of them, is a money that we have got us to develop in order to earn it and then we're also able to fully be in our had thing together because the name is of your key to that. So that's something that's fully being truly important to one. Paul, thank you. Second one for me. Just kind of piggybacking on this day. We'll agree with the other product. That opportunity a little bit more. You're very familiar with your logic. Building a brand new industry. And you just give us a little more of our opinions. What is it really, really take up like one for you? And we're excited about that. So we'll both start happening together at the same time.
Wade King: And with that, I'll pass the floor over to you.
Wade King: Thank you, Peter. Looking at our financials for the second quarter, cash-in-cash report for $30 million by June 30, 2024. Moving to our income statement, I would like to start by noting that the second quarter, 2024, isn't directly comparable to that of the prior year's second quarter. Looking at our financials for the second quarter, cash-in-cash report for $30 million by June 30, 2024.
Speaker Change: [inaudible]
Wade King: The second quarter of 2024 is directly comparable to that of the prior year's second quarter of 2020. R&D expense was $13 million in the first quarter of 2024, at $8.4 million in the year-ago period.
Wade King: Specifically, the prior year period was only intended to increase the land supply and facility expenses. However, an increase in employment had to be made.
Speaker Change: [inaudible]
Wade King: and an increase in stock-based offices and expenses for restricted stock awards.
Speaker Change: I'm...
Speaker Change: [inaudible]
Wade King: decreased from 1.1 million to 6.5 million in time.
Wade King: This year's major expense was $9.3 million. This was partially offset by an increase in rent, an increase in consultant legal fees, and an increase in stock-based compensation expense for constricted stockholders. $6.5 million in one-time expenses were added to the co-expense of non-cash loans.
Speaker Change: to be in the position to start shipping. So it's a big category. We're going to start with fragrances and then move to oils. My one question for today is Are you planning on transferring HD1, HD3 stack trades to customers only in the stack?
Wade King: Where is the line available to the folks that were not cashed in a year ago?
Speaker Change: version In rice or do you think you would be transferring them? By myself
Wade King: This is related to the liability of Sue in Grant 31-2021.
Speaker Change: That's a great question. My one question for today is, are you planning on transferring HB1 and HB2 SAC traits to customers only in SAC versions in rice?
Wade King: with a net loss of $28.5 million in 2020.
Wade King: [inaudible]
Speaker Change: and more and really saying is the train train is going to happen. That's a great, quite great, as I'm wondering where we'll offer each train. But it'll be the first time that we'll start developing train. We need to do it in the race. We plan for it. If you're out of her body, if you're working on it, to try to really do that. It's the same thing we think is going to have to, and have it available, so that we're going to be leading it. I mean, where you are, the thing we'll see that come to rate. We'll see a lot of reach. They'll rate soon. They'll be able then it will kick start developing. It's best for us. It acts to where you get these open. And we're not so bad. We're not so bad. We're not so bad. We're not so bad. We're not so bad.
Wade King: For additional details about our financial statements for the quarter of 2020-2023, please refer to our previously recorded webinar.
Wade King: Netlaw, Justin Cornish, Isaac M. Young, Shubhash Ghaishin, Prithvi Rao, Kipnata, Shubhash Shukla, Anwar J. S. Kolk, Shubhash J. M. D. Shukla, Anwar J. Shukla, Shubhash J. M. J. K. K. K. K. K. K. K. K. K. K.
Wade King: As we explained, this quarter has been very important for a number of reasons. This has been an important period for building our weed management platform in rice. We've entered the quarter with four leading seed company customers in rice, representing approximately 40% of the addressable acres. In addition, with our recent field studies for side traders, we've begun to build our product off of a set of essential orders for a number of weed management solutions. This has been an important period for building our weed management platform in rice. The progress made this quarter with four leading seed customers in rice, representing approximately 40% of the addressable acres.
Speaker Change: Peter, let me add a little bit to that because I don't think this is such a great question. And if this is one of the things that I'm most excited about being, I will be the brain for the mock group.
Wade King: With our recent field studies for SAC and TRACE, we have begun to build conclusions to establish our
Wade King: The progress in advanced trades is key, as they are the backbone of our current trade offering in canola, where we have 10 customers. In addition, these trades are expected to be the backbone of our product offerings in soybeans. And this concludes our remarks, Operator.
Speaker Change: [inaudible]
Operator: We will take our first question from Scott Fortune using the Request Star 100 telephone keypad. Hey, good afternoon. This is Nick Offerstott.
Nick Offerstad: Congratulations on the quarter. The first one for me, just on the soybean side, getting up to speed there. Wanted to unpack that market opportunity a little more and just the timing around monetizing and maybe reaching some of the other milestones you've mentioned achieving in that segment.
Nick Offerstad: Hey, good afternoon. This is Nick Offerstad. Congratulations on the corner. The first one for me is on the soybean side. We're making our conversion.
Speaker Change: [inaudible]
Peter Beetham: where we get the pipeline approved, and when the pipeline is validated, by 2012, we will one by one sign with the partners. It's a very complicated process.
Peter Beetham: We will do them one by one.
Peter Beetham: We're already working on a couple of GDMs, so we believe the top four in America are all contributing to our crops. And so we'll start by editing their crops if you want to make editing a year-end this year. And so what we do next is as to where we get the next year's pipeline and improve development.
Speaker Change: Haven't had those opportunities
Speaker Change: So that's why I think, you know, bringing HD3, HD1, and others to the marketplace, not just in the U.S., but Latin America, and into the Asian markets is very exciting that we've made so much progress in such a short amount of time. Thank you guys. Not just recently, thank you. Yep, thank you guys.
Speaker Change: of the first thing you're doing for Scarlett Union, any of you too, and Scarlett Union, you have two different modes of action, so you have to feel a lot of pain and a really exciting character that we're dealing with, and we're really getting into the blockbuster with three weeks. You're waiting first for Justin Greenhouse to go through the video, and I need to let us feel in the next year. The first thing you're doing for Scarlett Union, I don't say the same thing to you. [inaudible]
Peter Beetham: We're excited about that, so they'll both start happening together at the same time. This is an investment that's been funded by the corporation. We've been funded. P&G has funded us through this project to date to develop these products, and they intend to work with other consumer product companies. So we think this is a sustainable ingredient.
Speaker Change: until next year.
Rory Riggs: We talk about the nodes of action for disease resistance, and it's important to understand that's the beauty of what Cibus is doing. Rory often talks about it, and because we have customers, and the analogy in the pharmaceutical industry, and this is the same.
Peter Beetham: So this is an investment that's being funded by other corporations, so we've, they have a fragrance business, and P&G has funded us.
Peter Beetham: really big category across many of the They have a fragrance business. P&G has funded us, and it's a very, very good company to develop these products, and they intend to do this as an extension of their other consumer products, and we'll take the product from it, and we'll work very closely with them. Shipping across many of the fragrance-like products next year.
Speaker Change: We talk about the mode of action is the ability to give a durable resistance to crops, that's the beauty against diseases like sclerotinib. So we're excited to see the second half of this year with the third mode of action, as Rory said, in our chambers and greenhouses to validate that having multiple modes of action for disease resistance is the ability to give durable resistance to crops. The third mode of action is sclerotinib, so we're excited.
Speaker Change: and the Cuffing and the Huff that we were supposed to do and we played with that kind of, you know, a great time in the green house. We know it's one of the, we don't go like straight, good ever to talk to about ready and think of this as what we do, the other bed of action. Bringing you all together, you connect about, and the Cuff is on our left hand also. We don't do and then we have, you know, we have franchise. We understand what we do, one of the, to address complex times we've talked about. Next day, we're just showing what we've told on to address those, those, those, like, traits. You've asked about and then with regard to any ways and also, you know,
Matthew Van Veen: Great visit from you. I appreciate the time. I'll take the time. Thank you. We'll take our next question from Matthew Van Veen with Alliance Global. Would you please go ahead?
Matthew Van Veen: I'll take category A; we'll start with fragrances and then move to oils and then come to soybeans. My one question for today is, are you planning on transferring HB1 into HB2?
Matthew Van Veen: http://www.youtube.com
Speaker Change: And we're excited because I think that for H&T, as I mentioned in my remarks, it is one of the biggest opportunities we have globally, and bringing forward the NUE trades, the first set of edits is just the first generation, and we'll look forward to reporting on those later this year.
Peter Beetham: That's a great question. My one question for today is, are you planning on transferring HB1, HB3, and ZAC traits to customers only in ZAC versions of rice, or do you think you would be transferring them separately at all, just like HB1 would help for HB3 by itself? That's a great question. I'm on the stage where we'll offer each trade individually, and then we'll start developing ZAC traits with each of them individually.
Rory Riggs: As I mentioned in my remarks, it is one of the biggest opportunities we have.
Peter Beetham: And then we'll start developing stack traits with each of them individually. We've got four different repositories that we're working on right now. And what we're really saying is that the same things that we're going to have to have available so that we're going to be leading it.
Rory Riggs: conservative, and bringing forward the enumelory, the first set of edits is just the first generation to reporting on those later this year.
Peter Beetham: The same thing is going to have to happen in the non-gay world.
Speaker Change: No, we have three big platforms. Weed, disease, and end-to-be-following. Our focus right now is really to make sure these get going and these start making money and we can break out of it. Our focus has really been on theirs. There's nothing we're doing that's going to stop the growth and building of those. No, we have three big platforms. Weed, disease, and end-to-be-following. Our focus right now is really to make sure these get going and these start making money and we can break out of it. Our focus has really been on theirs. There's nothing we're doing that's going to stop the growth and building of those.
Peter Beetham: You really have 15,000. With one, you have a different kind of group there.
Peter Beetham: We're pretty excited. That's what I'm going to do; I'm going to take the lead on the whole group. We'd manage it physically, we'd manage it because that's helpful to offer a seed that has a bunch of different ways for the farmer to manage the weeds and do that at a different level. Yeah, let me add a little bit to that because I think that's a great question and it is one of the...
Rory Riggs: Rationalizing and understanding.
Rory Riggs: what we need to build the rest of the system, which is the big thing that we care about, which is getting these herbicide tolerance in rice and wheat. It's a really big category, and we already have a bunch of herbicides.
Peter Beetham: is to control their weight, and this is called weight management.
Peter Beetham: Let me add a little bit to that because I think this is a great question.
Speaker Change: I have to feel that it's really important to those presentations, best of you guys with the D.D.K.
Speaker Change: I'm the first one in the day, especially there will be, there has been a familiar meeting on the question for Mr. Neil Jones, who is going to say what he's going to say when he's going to go ahead.
Peter Beetham: and I'm actually excited about being able, across the crop, to the market, you know, um, um, there are opportunities for farmers to control their wheat, you know, as I mentioned.
Peter Beetham: As I mentioned, it can be as much as $120 per acre in 12 weeks, so globally, you know, bringing forward that productivity.
Speaker Change: In this, yeah, thank you for taking my call. I have not used a few clarification on a little ongoing demonstration of the interview with Peter Beetham.
Speaker Change: I'm going to give you a piece of that to try and get in here. Yeah. I think our part of the exercise are more sized. Do you think that's the time to get a career? Yeah. Really? Yeah. And we're going to make great progress on the same. That's what I'm going to do. You have a two-year-old really, a three-year-old, and probably a three-year-old. I'm going to do something to try and change it.
Peter Beetham: As Custler mentioned, one is excited to call up the farmers that the C Company is able to reach.
Peter Beetham: All that fly on, provide those prayers and all that.
Peter Beetham: on offering, you know, as I mentioned.
Peter Beetham: So, you know, it can be as much as $120 per page.
Peter Beetham: control, resistance management, and having the long-fored SAC trade, and as Rory said, as Soya and Cory mentioned, one of the exciting things that have been done with GMOs is that feed companies are being able to provide those...
Peter Beetham: Right. Haven't had those opportunities. So that's why I think it helps with regard to
Speaker Change: and we're really excited about it. I think our partners are more excited than we are. We're ready as we could be. I agree, Rory. I think what's been exciting and encouraging over the last six months at Cibus is the
Peter Beetham: HGY Distance Management and multiple staff, not just in New Zealand but Latin America and into Asian markets.
Peter Beetham: The Asian Markets, but it has been done with TMOs, so we've made so much progress in such a short amount of time, and RICE hasn't had those opportunities, so that's why I think you know.
Peter Beetham: Robert Cheney
Speaker Change: There's an appetite for plant-based solutions, and as Rory's mentioned, we've got some partnerships already with companies that want to fund this research.
Peter Beetham: and into the Asian markets. It's very exciting that we've made so much progress in such a short amount of time.
Speaker Change: It's not just Soybean. I didn't encourage beyond that as well. I know it's weird. We're seeing a real appetite in the mind. People coming to us in Athens, like, for the final group strategy of Spain. We really need to know this, but sustain our mission. We're really with company and one of the funds, and it really does meet there. It's not just Soybean. Part of that beyond that as well. We stand even with, like, we're saving fuel, a real appetite in the mind for oil profile. People coming to us always don't really grade a base for our strategy. I think we really need to move forward, sustain and grow in other crops. We've talked about before, like, any of these does meet where we really need oil and fire. How did that happen?
Peter Beetham: Not to create something new. Yep, exactly.
Operator: Thank you. We'll take our next question from Austin Moeller with Canaccord, please.
Austin Moeller: Peter, good afternoon. In each of those, the first thing you're doing for Sclerotinia and HP2, in Sclerotinia you have two different modifications; we've had field studies and are really excited about that. Our third, which we think is really going to be the blockbuster, is a three. You're waiting first for just greenhouse data and growth data, and we're going to field some next year. The first thing you're doing for Sclerotinia and HP2, in Sclerotinia, you have two different modifications; we've had field studies and are really excited about that. And our third, which we think is really going to be the blockbuster, is a three. You're waiting first.
Wade King: Coinconcene, Cringing of the church, one here, one in the middle, for the social media also known
Speaker Change: [inaudible]
Speaker Change: and then he flew in there and we'd like to be moving forward, finding our towards the other side. We've just found out we've got a very nice, exciting way that we've tried to find Rose, plant a base.
Austin Moeller: because we've made the effort. The next step in the effort is to talk to that space right now.
Speaker Change: Opportunity, yes, we're just human health, non-allergenic peanuts, there's lots of us, as you can see, they're in the fun way to buy, there are monsters in there and where we're getting our work, we're going to have to build some of these opportunities and build them a whole week. It's a very work of starting areas, you know, that's not a vast right, we're going to find the time and build the business. We're going, if it's, yeah, exactly, no, yeah, and I also know that they say that this opportunity. That's a good, is they're funding the box, they're funding that they want. That's what they're in there and they're scoping out of where the way you could. Yeah, how the build was in drilling and there's nothing I think it's um, I think we'd look at it as well. Right, so we can know what we're working on. We work in the office, but probably we must, they're customer, all around the, really think I don't want to do this with them.
Austin Moeller: is doing. Rory often talks about antibiotics as an analogy.
Austin Moeller: In thelessamic statute of the cities, and this is the time for us to have multiple nouns in the action. Stage resistance is
Austin Moeller: and it's important to understand that that's what the beauty against diseases like sclerotinibus is doing.
Austin Moeller: So we're in silent. Rory often talks about antivirals.
Austin Moeller: Now we're in the pharmaceuticals and greenhouse industries, and this is the same, to validate that we know it's going to work.
Austin Moeller: For Disease Resilience, we've got, you know, good evidence.
Speaker Change: Take us through our current expense a little bit more importantly to build the business here. We think it's built.
Austin Moeller: All together, we're excited to see the customers.
Austin Moeller: and all of our franchises, and we see them very clearly.
Speaker Change: [inaudible]
Austin Moeller: Our franchisors, and Greenhouse; we see them very closely.
Speaker Change: The ability to talk about the side door that's key to get over our current external door, so we take riddills.
Austin Moeller: we do, the other modes of action, bringing them all together.
Austin Moeller: And they're the same, you know; we have...
Peter Beetham: What did Peter do? I think the kids came as a bearers, and we may have just one by one. It's kind of just proven, but really just, you know, obviously it's a big, no, it's a time and I think the reason, but it's sort of, it's a really good example of all around the world. We're all starting to improve it. And they're all passing when they're, well, you know, we're just in the category where we're regular. What did Peter do? I think the kids came as a bearers, and you, hey, maybe small, but one of the one that I wanted to do is we're a little bit of a trial that you really just said, you know, that obviously it's a big filter. No way. It's a crazy time and I think it's the one that's, it's from the whole idea that it is.
Austin Moeller: and their essays already. We see them for each study. We understand what we do.
Austin Moeller: of showing that the crop is tolerant to that particular herbicide.
Austin Moeller: You asked about herbicide tolerance and also NUE. That's something we have actually worked on because, as I mentioned in my remarks, it is one of the biggest opportunities we have. Our goal is to bring forward NUE.
Austin Moeller: and bringing forward the NUE traits, and then with regard to NUE.
Speaker Change: I really don't want to be alone in this field. We're alone in all fields of technology. We can make these edits and make them in a category that we're regulated by. I think my team is excited about Canada, and we're particularly excited about our first field trial in the U.K. And we'll soon announce the results of the field trial. Excuse me, I'll just add a little bit, thanks. I love flying across Canada and seeing how much yellow and brown there is. There's 22 to 25 million acres of canola in the prairies. We've got a really strong wheat market. Excuse me, I'll just add a little bit, thanks. I love flying across Canada and seeing how much yellow and brown there is.
Austin Moeller: This is just the first generation, and we'll look forward to reporting on those.
Austin Moeller: We look forward to reporting on those later this week. No, we have three big platforms.
Austin Moeller: Weed, Disease, and the Weed Following. But our focus right now is really to make sure these get going, and these are...
Speaker Change: We are one of the only in England, and so Canada has come out in the fairies, and we're not only that, but we've also got everything strong.
Austin Moeller: Shelly is there as well.
Austin Moeller: There's nothing we're doing that's going to stop the growth and building of those. No, we have three big parts.
Speaker Change: wheat market and soybeans moved north as well.
Austin Moeller: Rationalizing and understanding these, what we need, and the big things that we care about. Our focus right now is really to make sure these get going. Herbicide tolerance in rice and wheat is really a big category, and we already have a bunch of herbicides that work for us.
Speaker Change: So, you know, you've got three of our crosses that we're working on. So Canada is one of our key markets for sure. And they do have an environment where sclerotinia resistance would be pretty important.
Austin Moeller: There's nothing we're doing that's going to stop the growth. We're really working to delve into the process, rationalizing and understanding what we need to build the recipes.
Speaker Change: [inaudible]
Austin Moeller: Excellent. Thanks for the details. It's a big thing that we care about, which is getting herbicide tolerance in rice and wheat, which is a really big category, and we already have a bunch of herbicides that work with disease.
Sameer Joshi: We haven't really worked out the process yet. Excellent. Thanks for the details. Thank you, and we'll take our next question from Sameer Joshi with AC Weimar. Please go ahead. Thank you for taking the call.
Speaker Change: [inaudible]
Sameer Joshi: I think our partners are as excited or more excited than we are. Can you repeat that just so I'm getting it clear? It was really about increased funding, and we made great progress on that.
Speaker Change: of the United States. I mean, it costs for us. Which one is in total cost spend? Possibly. Thank you. Thank you. Thanks for that. Congratulations. Thank you. It's just curious. What's the mechanism of action behind this nitrogen. Thanks, friend. I'm curious. What's the mechanism of action behind this nitrogen. Thanks, friend. I'm curious. What's the mechanism of action behind this nitrogen. I'm curious. What's the mechanism of action behind this nitrogen. Or nutrient use efficiency. Thanks. Reducing.
Sameer Joshi: I think we're all fairly excited about this. This increase in funding was...
Sameer Joshi: I agree, Rory. I think what's been exciting and encouraging over the last six months is
Sameer Joshi: What's been exciting and encouraging over the last six months at Cibus is that there is an appetite for plant-based solutions, and as Rory mentioned, we've got some partnerships already with companies that we agree with.
Sameer Joshi: It's not just soybeans; I think it's in the Caribbean as well, for the last six months.
Speaker Change: Let me start by saying that we never quoted them, this is one of the first times we have worked with them. We're working with a lot of them to assimilate the nutrients that are in the soil to our canola platform.
Sameer Joshi: We're seeing a real appetite in the market for people coming to us with a plant-based strategy.
Sameer Joshi: of saying that we really need a sustainable partnership.
Sameer Joshi: but a sustainable partnership already with companies that want to fund this research. And it really does meet their profitability goals. It's not just soybeans. So part of that is beyond that as well.
Speaker Change: Thank you very much.
Sameer Joshi: And even with like twisting you in the middle.
Sameer Joshi: .. .. .. .. .. ...
Sameer Joshi: Bukowski.
Sameer Joshi: And it really does meet their sustainability goals.
Sameer Joshi: I'm sorry, part of that is, you know, opportunities and things like, different fuels for human health, you know, non-allergenic peanuts. There are lots of opportunities in the space. And this is an area where we'd love to move forward funding towards some of these opportunities that we've talked about before, like peanuts, exciting areas that, you know, we've...
Sameer Joshi: Where we've got the most blatant opportunities that we could ever have.
Sameer Joshi: opportunities for human health, non-allergenic peanuts. There are lots of opportunities in this space, and this is an area where we're getting funding for some of these opportunities.
Sameer Joshi: [inaudible]
Speaker Change: But within the plan, we hope to also bring along other edits that have a multi-factorial way of getting to nutrient use efficiency. We're looking at multiple ways to enhance the use of nutrients in crops.
Speaker Change: I'm sorry. Good. And then one question on this alert. Can you trade? But within the plan. Is there any risk to that, or successful at putting that head in? That's what we like. That it might have a different, a fact. Yeah. Really cool. And then it doesn't canola.
Sameer Joshi: As I said, they're funding the buy because they want to. They're scoping out where to farm and how to build it. It's really interesting. I think we'd look at it as rice, canola, and dirt. We weren't going to go after alcohol, probably. But they're all in three really big central businesses.
Speaker Change: Hmm.
Speaker Change: [inaudible]
Sameer Joshi: Both of them have the ability to take us to our expenses.
Speaker Change: Is there any risk that if you are successful at...
Sameer Joshi: take us through our current expenses a little more, partly to build a business.
Speaker Change: [inaudible]
Sameer Joshi: Yeah, it's really interesting. I think we look at it as rice, quinoa, rice, oats, pine, soybeans. They're all three really big types.
Speaker Change: a different effect on fungal resistance than canola, or are you confident in that ability? We really get it with the testing. The work that we've done in our R&D team, the work that we have done, and the assays we've analysed, give us a lot of comfort that we are going to be successful.
Sameer Joshi: I think the key is Caine is a very respected market; one by one, these countries approve it. It's really just, obviously it's big for canola, it saves time on increasing, but it's a really good example of how around the world they're all starting to approve it, and they're all passing the same things, but that's in the category where we're regulated. I think the key is Caine is a very respected market; one by one, these countries approve it. It's really just, obviously it's big for canola, it saves time on increasing, but it's a really good example of how around the world they're all starting to approve it, and they're all
Speaker Change: We are able to do some early update now.
Speaker Change: [inaudible]
Sameer Joshi: thing, but it's hard not to.
Speaker Change: They say a lot of questions here on the Demonstration for Good Reason, they're really...
Speaker Change: Both are advanced trades for potential dollar rules. As I said at the end, we're most excited about how far we're moving this rice market pretty closely. That's a good example of how we've managed that dollar value. Thanks so much, guys, and look forward to next quarter.
N.: and N.
N.: [inaudible]
Sameer Joshi: I don't want to be alone in this field. There are 22 to 25 million acres of granola in the prairies. And so, not only that, you've also got a really good chance...
Sameer Joshi: Market, excuse me, I'll just have a little bit.
Sameer Joshi: Across Canada, you've got three of our...
Sameer Joshi: And so, Canada is one of our key markets.
Sameer Joshi: I think you'll see that pretty consistently ahead. Remember, this is the last quarter we'll be recording, you know, results for the comparable year, the comparable period from the previous year.
Sameer Joshi: Bob Gillens, and so we've got a good bunch of results with activity, comparable production activity.
Sameer Joshi: and a good bunch of results with activity, comparable production activity.
Sameer Joshi: I could be the C.S.T., and S.G. Mizzurin could be the C.S.T.
Sameer Joshi: All in all, it's a total success. We have a good range of artistic development activities.
Sameer Joshi: Thanks for that. Congratulations on the fundamentals of the business.
Sameer Joshi: Thanks, Ben. We're moving. Each of the platforms is doing a pretty good job of signing on customers.
Operator: Thank you. We'll take our next question from...
Dave: I'm curious, what's the mechanism of action behind this nitrogen for nutrient use efficiency?
Dave: crop, or is this really more, uh, you know, system related?
Dave: Thank you. Just curious, what's the mechanism of action behind this?
Dave: What's the mechanism of action behind this?
Dave: Thanks Dave.
Dave: The nitrogen content in the crop is really more, you know, root system related, better ability to assimilate nutrients that are in the soil. We're excited. We might do that very quickly. It is more associated with nutrient uptake. We've reported on this, it's one of our first ones, so there are many modes of action that we're going to go after.
Dave: I won't go into the specifics today, but fundamentally, it is not just...
Dave: It is more MPK.
Dave: I like a lot of our opportunities.
Dave: opportunities, many modes of action, being able to go on complex studies, look at multiple ways. I won't go into the specifics today, but enhance
Dave: today, but fundamentally, it is not just nitrogen crops that we're looking at. So for us right now, it's more on the root side, fertilizer, opportunity, and I think that, like a lot of our other opportunities.
Nathan Albrich: Very good, and then there is one question on the Sclerotinia trait.
Austin Moeller: and the cast I've been in the clip, and also we...
Nathan Albrich: in the plant. It's a dirty recipe for that engine.
Nathan Albrich: that if you are successful at putting the edit into soybeans, that it might have a different effect... Nathan Albrich...on fungal resistance than it does in canola. Very good, and then one question on that: stability, is there any risk that if you are successful at bringing that edit into
Nathan Albrich: We have dozens of canola; we are confident in the ability to get it in the field to test it. The work that we have done would actually point to
Nathan Albrich: We are able to do some early assays now, you know, you have to get...
Operator: And there are no further questions at this time. I'll turn the call over to the management for any closing remarks.
Operator: As it says there,
Operator: And there are no further questions at this time. I'll turn this over to the management for any closing remarks.
Operator: Thank you. This does conclude today's program. Thank you for your participation. You may disconnect at any time.
Operator: Go to www.camstaple.com to order your Paper Menu Power
Wade King: [inaudible] Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus, Cibus,